Ling Li
6PUBLICATIONS
50CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 14, 2026
Hepatocyte SLCO4C1 is a cAMP uptake transporter for inhibiting lipogenesis and a therapeutic target for MASLD.Xiaojia Huang, Sen Liang, Nan Zhao
|Nov 25, 2025
Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease.Ziyu Li, Gang Luo, Changpei Gan
|Nov 06, 2024
Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population.Jingjing Ding, Huaizheng Liu, Xiaoxun Zhang
|Jul 10, 2024
Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation.Liangjun Zhang, Pingfan Xie, Mingqiao Li
|Jan 17, 2023
Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signaling.Liangjun Zhang, Qiong Pan, Lu Zhang
Pageof 1
Frequent Collaborators
6 joint publications
Qiong Pan
6 joint publications
Jin Chai
4 joint publications
Nan Zhao
4 joint publications
Xiaoxun Zhang
3 joint publications
Xinshou Ouyang
3 joint publications
Christopher D Byrne
3 joint publications
Shi-Ying Cai
3 joint publications
Minghua Zheng
2 joint publications
Liangjun Zhang
2 joint publications
James L Boyer
